Zobrazeno 1 - 10
of 16 974
pro vyhledávání: '"Oral Anticoagulants"'
Autor:
Alina Doina Nicoara, Andra Iulia Suceveanu, Ionut Eduard Iordache, Iulia Tania Andronache, Andreea Nelson Twakor, Andreea Georgiana Sunda, Ioan Cristian Nichita, Anca Pantea Stoian, Felix Voinea, Adrian Paul Suceveanu
Publikováno v:
Journal of Mind and Medical Sciences, Vol 11, Iss 2, Pp 363-373 (2024)
Managing anticoagulation therapy in individuals with atrial fibrillation who also have liver disease is highly challenging due to altered blood clotting processes and the risk of bleeding due to liver dysfunction. The literature highlights the comple
Externí odkaz:
https://doaj.org/article/93187e758bfe486db9f1bad8e49968ab
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 20, Iss 4, Pp 460-467 (2024)
The Beers Criteria are a tool for optimizing pharmacotherapy in elderly patients, containing information on potentially inappropriate drugs, which is only advisory in nature and is not mandatory for use in Russian Federation. In the updated version o
Externí odkaz:
https://doaj.org/article/802cbd04defc492d93b88c6ca7a71540
Autor:
A. V. Ponomarenko, A. D. Gavrilko, A. A. Gartung, M. S. Poliakova, A. A. Oganesyan, K. S. Benimetskaya, D. V. Losik, S. V. Shalaev
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 20, Iss 4, Pp 468-477 (2024)
Cardiology, like other branches of medicine, is increasingly faced with the need not only to optimize patient treatment, reduce financial costs, but also to improve long-term outcomes. The volume of information required for such tasks is significant,
Externí odkaz:
https://doaj.org/article/e337a0729752491c9a2f1ee3dca993d8
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
BackgroundOral anticoagulants (OACs) are essential for the prevention and treatment of thromboembolic disorders, but bleeding, a major complication, can have a fatal impact on the patient’s treatment.ObjectivesWe aimed to estimate the nationwide, r
Externí odkaz:
https://doaj.org/article/30f8d57ac53b493284eef9b57a982516
Publikováno v:
Неврология, нейропсихиатрия, психосоматика, Vol 16, Iss 4, Pp 111-121 (2024)
Every third or fourth ischemic stroke is cardioembolic. Prescribing oral anticoagulants can significantly reduce the risk of recurrent stroke, but this strategy requires the physician to have a firm orientation in the “efficacy – safety” coordi
Externí odkaz:
https://doaj.org/article/56e30f82e78c4ab28fa6ebc05895e54e
Publikováno v:
BMC Cardiovascular Disorders, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background The objective of this study is to investigate the incidence, potential risk factors, and clinical outcomes of incomplete device endothelialization (IDE) in atrial fibrillation (AF) patients undergoing Watchman left atrial appendag
Externí odkaz:
https://doaj.org/article/b71f721fed934381891b8f18e3d252f5
Autor:
Ian Eustace
Publikováno v:
Cerebrovascular Diseases Extra, Vol 14, Iss 1, Pp 101-104 (2024)
Externí odkaz:
https://doaj.org/article/00fdac6352074a95990f824230860a41
Autor:
Veale EL
Publikováno v:
Integrated Pharmacy Research and Practice, Vol Volume 13, Pp 101-114 (2024)
Emma L Veale Medway School of Pharmacy, University of Kent and University of Greenwich, Chatham Maritime, Kent, UKCorrespondence: Emma L Veale, Email e.l.veale@kent.ac.ukAbstract: The world’s population is ageing, with the number of those over 60 y
Externí odkaz:
https://doaj.org/article/9ef1cdc025374892a0b2f98bb1f553d5
Publikováno v:
BMC Geriatrics, Vol 24, Iss 1, Pp 1-10 (2024)
Abstract Background Nursing home residents with atrial fibrillation are at high risk for ischemic stroke, but most are not treated with anticoagulants. This study compared the effectiveness and safety between oral anticoagulant (OAC) users and non-us
Externí odkaz:
https://doaj.org/article/2393a952be0040019fff81d5db2be9cb
Autor:
Hiroya Hayashi, Akihiro Tsuji, Akiyuki Kotoku, Hiroyuki Endo, Naruhiro Nishi, Takatoyo Kiko, Ryotaro Asano, Jin Ueda, Tatsuo Aoki, Tetsuya Fukuda, Takeshi Ogo
Publikováno v:
Thrombosis Journal, Vol 22, Iss 1, Pp 1-8 (2024)
Abstract Background Direct oral anticoagulants are the established drugs for treating pulmonary thromboembolism. The advantage of direct oral anticoagulants over conventional therapy for clot lysis and right ventricular unloading in the acute phase r
Externí odkaz:
https://doaj.org/article/264b7a170d464c75ad6e188b5227d93f